Drug resistance profiles of Mycobacterium tuberculosis clinical isolates by genotype MTBDRplus line probe assay in Zambia: findings and implications.
Mundia Hendrix KangongweWinnie MwanzaMutende MwambaJonathan MwenyaJohn MuzyambaJudith MzyeceAmos HamukaleEmmanuel TemboDavy NsamaRehab ChimziziAngel MubangaBushimbwa TambatambaSteward MudendaKennedy LishimpiPublished in: JAC-antimicrobial resistance (2024)
isolates were susceptible to rifampicin and isoniazid while 35% were resistant. Consequently, a high prevalence of MDR-TB is of public health concern. There is a need to heighten laboratory surveillance and early detection of drug-resistant TB to prevent the associated morbidity and mortality.